Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs COLINZ LABOR - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA COLINZ LABOR ORCHID PHARMA/
COLINZ LABOR
 
P/E (TTM) x 65.2 25.1 259.8% View Chart
P/BV x 6.6 1.5 440.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ORCHID PHARMA   COLINZ LABOR
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-24
COLINZ LABOR
Mar-24
ORCHID PHARMA/
COLINZ LABOR
5-Yr Chart
Click to enlarge
High Rs1,35944 3,088.2%   
Low Rs37133 1,113.0%   
Sales per share (Unadj.) Rs161.527.9 579.1%  
Earnings per share (Unadj.) Rs18.71.9 969.9%  
Cash flow per share (Unadj.) Rs25.32.4 1,033.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs230.635.5 649.3%  
Shares outstanding (eoy) m50.722.52 2,012.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.41.4 386.3%   
Avg P/E ratio x46.120.0 230.6%  
P/CF ratio (eoy) x34.215.8 216.6%  
Price / Book Value ratio x3.81.1 344.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m43,87297 45,031.6%   
No. of employees `000NANA-   
Total wages/salary Rs m69628 2,492.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,19470 11,655.3%  
Other income Rs m3113 11,319.3%   
Total revenues Rs m8,50573 11,642.7%   
Gross profit Rs m1,1085 20,403.3%  
Depreciation Rs m3321 25,566.9%   
Interest Rs m1670 45,232.4%   
Profit before tax Rs m9197 14,145.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-312 -1,901.8%   
Profit after tax Rs m9515 19,520.3%  
Gross profit margin %13.57.7 175.1%  
Effective tax rate %-3.425.2 -13.5%   
Net profit margin %11.66.9 167.6%  
BALANCE SHEET DATA
Current assets Rs m7,90887 9,052.7%   
Current liabilities Rs m2,60022 11,914.5%   
Net working cap to sales %64.893.2 69.5%  
Current ratio x3.04.0 76.0%  
Inventory Days Days5054 92.1%  
Debtors Days Days871446 195.3%  
Net fixed assets Rs m7,63126 29,082.5%   
Share capital Rs m50725 2,013.5%   
"Free" reserves Rs m11,18764 17,398.9%   
Net worth Rs m11,69589 13,068.1%   
Long term debt Rs m1,2040-   
Total assets Rs m15,539114 13,679.7%  
Interest coverage x6.518.6 34.9%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.50.6 85.2%   
Return on assets %7.24.6 156.0%  
Return on equity %8.15.4 149.5%  
Return on capital %8.47.7 109.7%  
Exports to sales %80.50-   
Imports to sales %30.40-   
Exports (fob) Rs m6,594NA-   
Imports (cif) Rs m2,489NA-   
Fx inflow Rs m6,5940-   
Fx outflow Rs m2,7050-   
Net fx Rs m3,8890-   
CASH FLOW
From Operations Rs m1,26010 12,173.1%  
From Investments Rs m-3,120NA -4,457,557.1%  
From Financial Activity Rs m1,6702 72,626.1%  
Net Cashflow Rs m-19013 -1,494.6%  

Share Holding

Indian Promoters % 69.8 65.9 105.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.2 0.0 -  
FIIs % 1.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.2 34.1 88.5%  
Shareholders   36,363 3,116 1,167.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Orchid Pharma vs COLINZ LABOR

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Orchid Pharma vs COLINZ LABOR Share Price Performance

Period Orchid Pharma COLINZ LABOR S&P BSE HEALTHCARE
1-Day 3.83% -3.67% 0.59%
1-Month 20.67% 7.18% 0.90%
1-Year 168.25% 29.58% 45.75%
3-Year CAGR 54.28% 40.28% 19.50%
5-Year CAGR 142.68% 41.94% 26.04%

* Compound Annual Growth Rate

Here are more details on the Orchid Pharma share price and the COLINZ LABOR share price.

Moving on to shareholding structures...

The promoters of Orchid Pharma hold a 69.8% stake in the company. In case of COLINZ LABOR the stake stands at 65.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Orchid Pharma and the shareholding pattern of COLINZ LABOR.

Finally, a word on dividends...

In the most recent financial year, Orchid Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

COLINZ LABOR paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Orchid Pharma, and the dividend history of COLINZ LABOR.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4% Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4%(10:30 am)

Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.